B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CUL1

MOLECULAR TARGET

cullin 1

UniProt: Q13616NCBI Gene: 84543 compounds

CUL1 (cullin 1) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CUL1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1candesartan cilexetil [Supplementary Concept]1.956
2Cetylpyridinium Cationic bactericidal surfactant used as0.691
3ninhydrin0.691

About CUL1 as a Drug Target

CUL1 (cullin 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented CUL1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CUL1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.